Sign in
Diabetic Retinal Telescreening Program in a High-Risk Population Highlights Significant Rates of Retinal Pathology
Matthew P. Ohr, MD
Annual Meeting Talks
2020
Abicipar Phase 2 MAPLE Trial Supports Improved Safety for Patients with nAMD Following a Modified Manufacturing Process
Raj K. Maturi, MD
Updates from the Field
2019
Comparison of CRISPR-based Genome Editing of VEGF-A as Treatment Strategy for Choroidal Neovascularization
Glenn C. Yiu, MD, PhD
Category: Diabetic Retinopathy